Department of Internal Medicine, Genome Research Center for Allergy and Respiratory Disease, Division of Allergy and Respiratory Medicine, Soonchunhyang University Bucheon Hospital, Gyeonggi-do, Republic of Korea.
Pharmacogenet Genomics. 2013 Jul;23(7):341-8. doi: 10.1097/FPC.0b013e328361d4bb.
Aspirin-exacerbated respiratory disease (AERD) is characterized by the development of airway obstruction in asthmatic individuals following the ingestion of aspirin or other nonsteroidal anti-inflammatory drugs. TAPBP (TAP-binding protein, tapasin) is upregulated by eicosanoids, which act as potent inflammatory molecules in aspirin-related reactions. Thus, functional alterations in the TAPBP gene may contribute toward AERD.
We examined the relationship between the single nucleotide polymorphisms on the TAPBP gene and AERD.
A group of asthmatic patients (n=1252) underwent the oral aspirin challenge. Oral aspirin challenge reactions were categorized into two groups as follows: 15% or greater decreases in forced expiratory volume in 1 s or naso-ocular and skin reactions (AERD), or 15% or less decreases in forced expiratory volume in 1 s without naso-ocular and skin reactions (aspirin-tolerant asthma). Five single nucleotide polymorphisms of the TAPBP gene were genotyped.
Logistic regression analysis showed that the minor allele frequencies of TAPBP rs2071888 C>G (Thr260Arg) on exon 4 (P>0.05), which was in absolute linkage disequilibrium with rs1059288 T>C on 3'UTR, were significantly higher in the AERD group than in the aspirin-tolerant asthma group, and the P values remained significant after multiple comparisons (Pcorr=0.006, odds ratio: 1.37, 95% confidence interval: 1.11-1.69, additive model; Pcorr=0.009, odds ratio: 1.52, 95% confidence interval: 1.14-2.03, dominant model). Alpha-helical wheel plotting showed that 260Arg had greater hydrophilic helical property than 260Thr.
TAPBP polymorphisms may play a role in the development of AERD.
阿司匹林加重性呼吸系统疾病(AERD)的特征是在摄入阿司匹林或其他非甾体抗炎药后,哮喘患者出现气道阻塞。TAPBP(TAP 结合蛋白,tapasin)受类花生酸上调,类花生酸在与阿司匹林相关的反应中是强有力的炎症分子。因此,TAPBP 基因的功能改变可能导致 AERD。
我们研究了 TAPBP 基因上的单核苷酸多态性与 AERD 之间的关系。
一组哮喘患者(n=1252)接受了口服阿司匹林挑战。口服阿司匹林挑战反应分为两组:1 秒用力呼气量(FEV1)下降 15%或更多,或伴有鼻眼和皮肤反应(AERD),或 FEV1 下降 15%或更少,无鼻眼和皮肤反应(阿司匹林耐受哮喘)。对 TAPBP 基因的 5 个单核苷酸多态性进行了基因分型。
逻辑回归分析显示,exon4 上的 TAPBP rs2071888 C>G(Thr260Arg)的次要等位基因频率(P>0.05),与 3'UTR 上的 rs1059288 T>C 完全连锁不平衡,在 AERD 组中显著高于阿司匹林耐受哮喘组,且在多次比较后仍有显著意义(Pcorr=0.006,比值比:1.37,95%置信区间:1.11-1.69,加性模型;Pcorr=0.009,比值比:1.52,95%置信区间:1.14-2.03,显性模型)。α-螺旋轮图显示 260Arg 比 260Thr 具有更大的亲水螺旋特性。
TAPBP 多态性可能在 AERD 的发生中起作用。